Only MetS-VLDLs significantly reduced STIM1 in HL-1 cells, and the reduction was at both the transcriptional (0.81 ± 0.02-fold versus control, Figure 1a) and the translational levels (0.33 ± 0.03-fold versus control, Figure 1c). The gene discussed is STIM1; the disease is metabolic syndrome.